NFKB1 and neoplasm: Therefore, we considered that, the continuous activation of NF-κB during the process of B[a]P long-term exposure may also lead to the enhancement of functions of several ABC transporters, and affect the effective dose of anti-tumor drugs, reduce the sensitivity.